These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37943035)

  • 1. Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant
    Sorlí L; Luque S; Li J; Benítez-Cano A; Fernández X; Prim N; Vega V; Gómez-Junyent J; López-Montesinos I; Gómez-Zorrilla S; Montero MM; Grau S; Horcajada JP
    Microbiol Spectr; 2023 Dec; 11(6):e0296723. PubMed ID: 37943035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.
    Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP
    J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic stem cell transplantation with colistin and amikacin inhalation therapy.
    Sato M; Honda A; Maki H; Toyama K; Yamaguchi R; Ikeda M; Moriya K; Kurokawa M
    J Infect Chemother; 2022 Jan; 28(1):91-94. PubMed ID: 34518095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by
    Cebrero-Cangueiro T; Labrador-Herrera G; Carretero-Ledesma M; Herrera-Espejo S; Álvarez-Marín R; Pachón J; Cisneros JM; Pachón-Ibáñez ME
    Life Sci Alliance; 2022 Oct; 5(10):. PubMed ID: 35728946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with intravenous colistin for sinusitis, orbital cellulites, and pneumonia caused by multidrug-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in a patient with acute myeloid leukemia.
    Saito T; Takaori-Kondo A; Tashima M; Yamashita K; Iinuma Y; Takakura S; Nagao M; Ichinohe T; Ishikawa T; Uchiyama T; Ichiyama S
    Int J Hematol; 2009 Jun; 89(5):689-92. PubMed ID: 19308657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.
    Hachem RY; Chemaly RF; Ahmar CA; Jiang Y; Boktour MR; Rjaili GA; Bodey GP; Raad II
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1905-11. PubMed ID: 17387153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.
    Montero M; Horcajada JP; Sorlí L; Alvarez-Lerma F; Grau S; Riu M; Sala M; Knobel H
    Infection; 2009 Oct; 37(5):461-5. PubMed ID: 19499183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study.
    Gómez-Junyent J; Rigo-Bonnin R; Benavent E; Soldevila L; Padullés A; Cabo X; Tubau F; Ariza J; Murillo O
    Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):587-599. PubMed ID: 32440843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa].
    Pinilla-Rello A; Huarte-Lacunza R; Magallón-Martínez A; Cazorla-Poderoso L; Pereira-Blanco O; Pérez-Moreno M; Larrodé-Leciñena I; Martínez-Álvarez RM; López-Calleja AI
    Rev Esp Quimioter; 2021 Oct; 34(5):441-449. PubMed ID: 34154319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa.
    Naesens R; Vlieghe E; Verbrugghe W; Jorens P; Ieven M
    BMC Infect Dis; 2011 Nov; 11():317. PubMed ID: 22085766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
    Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa.
    Linden PK; Kusne S; Coley K; Fontes P; Kramer DJ; Paterson D
    Clin Infect Dis; 2003 Dec; 37(11):e154-60. PubMed ID: 14614688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.
    Tascini C; Gemignani G; Ferranti S; Tagliaferri E; Leonildi A; Lucarini A; Menichetti F
    J Chemother; 2004 Jun; 16(3):282-7. PubMed ID: 15330326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.